Bank of New York Mellon Corp - NUVATION BIO INC ownership

NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 126 filers reported holding NUVATION BIO INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of NUVATION BIO INC
ValueSharesWeighting
Q3 2023$692,249
-25.5%
516,604
+0.0%
0.00%
Q2 2023$929,497
+23.0%
516,387
+13.5%
0.00%
Q1 2023$755,564
-16.2%
455,159
-3.0%
0.00%
Q4 2022$901,171
-8.7%
469,360
+6.5%
0.00%
Q3 2022$987,000
-23.9%
440,523
+10.0%
0.00%
Q2 2022$1,297,000
-49.8%
400,468
-18.5%
0.00%
-100.0%
Q1 2022$2,584,000
-38.1%
491,371
+0.1%
0.00%0.0%
Q4 2021$4,172,000
+48.1%
490,868
+73.2%
0.00%0.0%
Q3 2021$2,817,000
+103.7%
283,370
+90.7%
0.00%
Q2 2021$1,383,000
+448.8%
148,573
+516.0%
0.00%
Q1 2021$252,00024,1200.00%
Other shareholders
NUVATION BIO INC shareholders Q3 2023
NameSharesValueWeighting ↓
Omega Fund Management, LLC 15,072,340$28,938,8939.75%
Aisling Capital Management LP 2,541,009$4,878,7373.22%
EDBI Pte Ltd 1,270,504$2,439,3683.11%
EcoR1 Capital, LLC 13,896,543$26,681,3630.81%
Deep Track Capital, LP 8,221,188$15,784,6810.66%
AlphaCentric Advisors LLC 325,000$624,0000.62%
683 Capital Management, LLC 2,500,000$4,799,9990.41%
BRAIDWELL LP 4,122,900$7,915,9680.26%
Abrams Capital Management 3,811,513$7,318,1050.26%
Redmile Group, LLC 3,031,009$5,819,5370.24%
View complete list of NUVATION BIO INC shareholders